tradingkey.logo

Eli Lilly Spokesperson Says No One Should Be Mass-Compounding Or Selling Knockoff Glp-1 Products Regardless Of How They’re Administered

ReutersFeb 7, 2026 10:28 PM

- Eli Lilly and Co LLY.N:

  • ELI LILLY SOKESPERSON: LOOK FORWARD TO DECISIVE STEPS FDA HAS ANNOUNCED IT WILL TAKE, AND WE URGE OTHER REGULATORS AND LAW ENFORCEMENT TO DO THE SAME

  • ELI LILLY SPOKESPERSON: NO ONE SHOULD BE MASS-COMPOUNDING OR SELLING KNOCKOFF GLP-1 PRODUCTS REGARDLESS OF HOW THEY’RE ADMINISTERED

Source text: [ID:]

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI